// App-Quantinova.ai

1657 : The role of interferon type I and type III receptors in rhinovirus induced allergic asthma

Researchers

Presenter

  • Krug J

Principal Investigators

  • Koelle J

  • Kiefer A

  • Vuorinen T

  • Xepapadaki P

  • Stanic B

  • Chiriac M

  • Akdis M

  • Zimmermann T

  • Papadopoulos NG

  • Finotto S

Medical Centers

  • Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

  • Department of Allergy and Pneumology, Children's Hospital, Friedrich‐Alexander‐ Universität (FAU) Erlangen‐Nürnberg, Erlangen, Germany

  • Department of Pathology, University of Turku, Turku, Finland

  • Musculoskeletal Infection AO Research Institute Davos, Davos, Switzerland

  • Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

  • Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland

  • Centre for Respiratory Medicine and Allergy, University of Manchester, Manchester, United Kingdom,

Locations

  • Germany

  • Finland

  • Greece

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved